Skip to main content

Advertisement

SpringerLink
Log in

Baseline thrombocytopenia in women with coronary heart disease increases incident acute coronary syndrome: insights from national inpatient database

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

There are paucity of data on gender-based differences in the effect of thrombocytopenia and coronary heart disease (CHD) towards development of acute coronary syndrome (ACS). We used National Inpatient Sample (NIS) database of the United States to assess the gender-based differences in the association of thrombocytopenia with CHD and the impact of thrombocytopenia on mortality, length of stay and hospitalization costs on ACS subgroup of CHD. Our analysis found that thrombocytopenia was associated with increased odds of CHD on univariate (odds ratio [OR] 1.31 (95% CI 1.30–1.32) p < 0.001) and multivariate (OR 1.36 (95% CI 1.34–1.38) p < 0.001) analyses. Thrombocytopenic CHD patients had increased odds of developing ACS only in women (OR 1.15, 95% CI 1.12–1.17, p < 0.001). Thrombocytopenia was found to be associated with poor short-term outcome in ACS subgroup of CHD with higher in-hospital mortality (OR 1.64, CI 1.58 to 1.71, p < 0.001), length of stay (3.4 days, CI 3.30–3.52, p < 0.001), and cost of hospitalization ($55,652, CI 53,717–57,587, p < 0.001). Thrombocytopenic women with ACS have greater odds of mortality compared to men. Our study suggests that thrombocytopenia among women with CHD is associated with increased odds of developing ACS. Women with ACS have greater mortality compared to men. Thrombocytopenic ACS patients have worse in-hospital outcome compared to patients with normal platelet count. We demonstrated association only and is not possible to establish causality with our study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Wang TY, Ou F-S, Roe MT et al (2009) Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice. Circulation 119:2454–2462

    Article  Google Scholar 

  2. Yadav M, Généreux P, Giustino G et al (2016) Effect of baseline thrombocytopenia on ischemic outcomes in patients with acute coronary syndromes who undergo percutaneous coronary intervention. Can J Cardiol 32:226–233

    Article  Google Scholar 

  3. Sinkovič A, Majal M (2015) The impact of thrombocytopenia on outcome in patients with acute coronary syndromes: a single center retrospective study. BioMed Res Int 2015:907304

    Article  Google Scholar 

  4. McClure MW, Berkowitz SD, Sparapani R et al (1999) Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experience. Circulation 99:2892–2900

    Article  CAS  Google Scholar 

  5. Mieres JH, Gulati M, Bairey Merz N et al (2014) Role of noninvasive testing in the clinical evaluation of women with suspected ischemic heart disease: a consensus statement from the American Heart Association. Circulation 130:350–379

    Article  Google Scholar 

  6. Mehilli J, Presbitero P (2020) Coronary artery disease and acute coronary syndrome in women. Heart Br Card Soc 106:487–492

    Google Scholar 

  7. Radovanovic D, Erne P, Urban P et al (2007) Gender differences in management and outcomes in patients with acute coronary syndromes: results on 20,290 patients from the AMIS Plus Registry. Heart Br Card Soc 93:1369–1375

    Article  Google Scholar 

  8. Birman-Deych E, Waterman AD, Yan Y et al (2005) Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors. Med Care 43:480–485

    Article  Google Scholar 

  9. Varas-Lorenzo C, Castellsague J, Stang MR et al (2008) Positive predictive value of ICD-9 codes 410 and 411 in the identification of cases of acute coronary syndromes in the Saskatchewan Hospital automated database. Pharmacoepidemiol Drug Saf 17:842–852

    Article  Google Scholar 

  10. Amsterdam EA, Wenger NK, Brindis RG et al (2014) 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task For ce on Practice Guidelines. Circulation 130:2354–2394

    Article  Google Scholar 

  11. Feudjo-Tepie MA, Le Roux G, Beach KJ et al (2009) Comorbidities of idiopathic thrombocytopenic purpura: a population-based study. Adv Hematol 2009:963506

    Article  CAS  Google Scholar 

  12. Enger C, Bennett D, Forssen U et al (2010) Comorbidities in patients with persistent OR chronic immune thrombocytopenia. Int J Hematol 92:289–295

    Article  Google Scholar 

  13. Willeit P, Zampetaki A, Dudek K et al (2013) Circulating micror NAs as novel biomarkers for platelet activation. Circ Res 112:595–600

    Article  CAS  Google Scholar 

  14. Wisman PP, Roest M, Asselbergs FW et al (2014) Platelet-reactivity tests identify patients at risk of secondary cardiovascular events: a systematic review and meta-analysis. J Thromb Haemost JTH 12:736–747

    Article  CAS  Google Scholar 

  15. Marcucci R, Grifoni E, Giusti B (2016) On-treatment platelet reactivity: state of the art and perspectives. Vascul Pharmacol 77:8–18

    Article  CAS  Google Scholar 

  16. Cirillo P, Golino P, Calabrò P et al (2003) Activated platelets stimulate tissue factor expression in smooth muscle cells. Thromb Res 112:51–57

    Article  Google Scholar 

  17. Fruchter O, Blich M, Jacob G (2002) Fatal acute myocardial infarction during severe thrombocytopenia in a patient with idiopathic thrombocytopenic purpura. Am J Med Sci 323:279–280

    Article  Google Scholar 

  18. Pordzik J, Pisarz K, De Rosa S et al (2018) The potential role of platelet-related micror NAs in the development of cardiovascular events in high-risk populations, including diabetic patients: a review. Front Endocrinol 9:74

    Article  Google Scholar 

  19. Cameron HA, Phillips R, Ibbotson RM, Carson PH (1983) Platelet size in myocardial infarction. Br Med J Clin Res Ed 287:449–451

    Article  CAS  Google Scholar 

  20. O’Malley T, Langhorne P, Elton RA, Stewart C (1995) Platelet size in stroke patients. Stroke 26:995–999

    Article  Google Scholar 

  21. Odell TT, Murphy JR, Jackson CW (1976) Stimulation of megakaryocytopoiesis by acute thrombocytopenia in rats. Blood 48:765–775

    Article  CAS  Google Scholar 

  22. Karpatkin S (1978) Heterogeneity of human platelets. VI. Correlation of platelet function with platelet volume. Blood 51:307–316

    Article  CAS  Google Scholar 

  23. Gremmel T, Kopp CW, Eichelberger B et al (2014) Sex differences of leukocyte-platelet interactions and on-treatment platelet reactivity in patients with atherosclerosis. Atherosclerosis 237:692–695

    Article  CAS  Google Scholar 

  24. Johnson M, Ramey E, Ramwell PW (1975) Sex and age differences in human platelet aggregation. Nature 253:355–357

    Article  CAS  Google Scholar 

  25. Jastrzebska M, Marcinowska Z, Oledzki S et al (2018) Variable gender-dependent platelet responses to combined antiplatelet therapy in patients with stable coronary-artery disease. J Physiol Pharmacol. https://doi.org/10.26402/jpp.2018.4.10

    Article  PubMed  Google Scholar 

  26. Wada H, Miyauchi K, Daida H (2019) Gender differences in the clinical features and outcomes of patients with coronary artery disease. Expert Rev Cardiovasc Ther 17:127–133

    Article  CAS  Google Scholar 

  27. Russ MA, Wackerl C, Zeymer U et al (2017) Gender based differences in drug eluting stent implantation-data from the German ALKK registry suggest underuse of DES in elderly women. BMC Cardiovasc Disord 17:68

    Article  Google Scholar 

  28. Hakim DA, Dangas GD, Caixeta A et al (2011) Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial. Am Heart J 161:391–396

    Article  Google Scholar 

  29. Gore JM, Spencer FA, Gurfinkel EP et al (2009) Thrombocytopenia in patients with an acute coronary syndrome (from the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol 103:175–180

    Article  Google Scholar 

  30. Oikonomou EK, Repanas TI, Papanastasiou C et al (2016) The effect of in-hospital acquired thrombocytopenia on the outcome of patients with acute coronary syndromes: a systematic review and meta-analysis. Thromb Res 147:64–71

    Article  CAS  Google Scholar 

  31. Kwakman JJM, Simkens LHJ, Mol L et al (2017) Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: a retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group. Eur J Cancer 76:93–99

    Article  CAS  Google Scholar 

  32. Peng J, Dong C, Wang C et al (2018) Cardiotoxicity of 5-fluorouracil and capecitabine in Chinese patients: a prospective study. Cancer Commun 38:22

    Article  Google Scholar 

Download references

Funding

No external funding was available for this research.

Author information

Authors and Affiliations

  1. Division of Cardiology, Garden City Hospital, Garden City, USA

    Sharan P. Sharma, Rahul Chaudhary, Priya Gupta, Snigdha Kondur, Nitya Gatla, Sonella Blaceri, Nishit Choksi, Elias Kassab, Nistha Sareen & Ashok Kondur

Authors
  1. Sharan P. Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rahul Chaudhary
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Priya Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Snigdha Kondur
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nitya Gatla
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sonella Blaceri
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Nishit Choksi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Elias Kassab
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Nistha Sareen
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Ashok Kondur
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ashok Kondur.

Ethics declarations

Conflict of interest

The authors declare that they have no conlict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sharma, S.P., Chaudhary, R., Gupta, P. et al. Baseline thrombocytopenia in women with coronary heart disease increases incident acute coronary syndrome: insights from national inpatient database. J Thromb Thrombolysis 50, 462–467 (2020). https://doi.org/10.1007/s11239-020-02096-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-020-02096-6

Keywords

Search

Navigation